These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26236031)

  • 21. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
    Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
    Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.
    Rayavarapu S; Coley W; Cakir E; Jahnke V; Takeda S; Aoki Y; Grodish-Dressman H; Jaiswal JK; Hoffman EP; Brown KJ; Hathout Y; Nagaraju K
    Mol Cell Proteomics; 2013 May; 12(5):1061-73. PubMed ID: 23297347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Protocol for Simultaneous In Vivo Imaging of Cardiac and Neuroinflammation in Dystrophin-Deficient MDX Mice Using [
    Tang JM; McClennan A; Liu L; Hadway J; Ronald JA; Hicks JW; Hoffman L; Anazodo UC
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
    Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
    Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
    Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
    Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
    Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
    Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of pharyngeal dilator muscle force in dystrophin-deficient (mdx) mice following co-treatment with neutralizing interleukin-6 receptor antibodies and urocortin 2.
    Burns DP; Rowland J; Canavan L; Murphy KH; Brannock M; O'Malley D; O'Halloran KD; Edge D
    Exp Physiol; 2017 Sep; 102(9):1177-1193. PubMed ID: 28665499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
    Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
    Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered acetylcholine release in the hippocampus of dystrophin-deficient mice.
    Parames SF; Coletta-Yudice ED; Nogueira FM; Nering de Sousa MB; Hayashi MA; Lima-Landman MT; Lapa AJ; Souccar C
    Neuroscience; 2014 Jun; 269():173-83. PubMed ID: 24704431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background.
    Rodrigues M; Echigoya Y; Maruyama R; Lim KR; Fukada SI; Yokota T
    Sci Rep; 2016 Dec; 6():38371. PubMed ID: 27924830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice.
    Vaillend C; Chaussenot R
    Hum Mol Genet; 2017 Mar; 26(6):1041-1055. PubMed ID: 28087735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy.
    Kreis R; Wingeier K; Vermathen P; Giger E; Joncourt F; Zwygart K; Kaufmann F; Boesch C; Steinlin M
    NMR Biomed; 2011 Apr; 24(3):253-62. PubMed ID: 21404337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Alzheimer's disease-like neuropathology in Duchenne's muscular dystrophy using the DBA/2J mdx mouse model.
    Hayward GC; Caceres D; Copeland EN; Baranowski BJ; Mohammad A; Whitley KC; Fajardo VA; MacPherson REK
    FEBS Open Bio; 2022 Jan; 12(1):154-162. PubMed ID: 34668666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy.
    Manning J; Kulbida R; Rai P; Jensen L; Bouma J; Singh SP; O'Malley D; Yilmazer-Hanke D
    Exp Physiol; 2014 Oct; 99(10):1370-86. PubMed ID: 24972834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dystrophinopathy-associated dysfunction of Krebs cycle metabolism.
    Lindsay A; Chamberlain CM; Witthuhn BA; Lowe DA; Ervasti JM
    Hum Mol Genet; 2019 Mar; 28(6):942-951. PubMed ID: 30476171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [WEAK COMBINED MAGNETIC FIELDS ADJUSTED TO THE PARAMETRIC RESONANCE FOR Ca2+ INTENSIFY DYSTROPHIN SYNTHESIS IN MDX MICE SKELETAL MUSCLES AFTER CELL THERAPY].
    Sokolova AV; Sokolov GV; Mikhailov VM
    Tsitologiia; 2016; 58(2):150-5. PubMed ID: 27228662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.
    Nico B; Frigeri A; Nicchia GP; Corsi P; Ribatti D; Quondamatteo F; Herken R; Girolamo F; Marzullo A; Svelto M; Roncali L
    Glia; 2003 May; 42(3):235-51. PubMed ID: 12673830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.